AIM ImmunoTech Inc.
AIM
$9.21
$0.9110.96%
AMEX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 2.25M | 3.98M | 7.20M | 10.06M | 10.94M |
Total Receivables | 19.00K | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 318.00K | 199.00K | 368.00K | 300.00K | 364.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 2.58M | 4.18M | 7.57M | 10.36M | 11.31M |
|
|||||
Total Current Assets | 2.58M | 4.18M | 7.57M | 10.36M | 11.31M |
Net Property, Plant & Equipment | 652.00K | 726.00K | 770.00K | 809.00K | 881.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 2.27M | 2.59M | 2.53M | 2.49M | 2.31M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 745.00K | 1.11M | 2.72M | 2.05M | 1.69M |
Total Assets | 6.25M | 8.61M | 13.59M | 15.72M | 16.19M |
|
|||||
Total Accounts Payable | 6.94M | 6.38M | 6.26M | 5.46M | 6.57M |
Total Accrued Expenses | 639.00K | 606.00K | 1.01M | 799.00K | 1.45M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.18M | 2.55M | 2.83M | 2.59M | 1.86M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 9.77M | 9.54M | 10.10M | 8.84M | 9.88M |
|
|||||
Total Current Liabilities | 9.77M | 9.54M | 10.10M | 8.84M | 9.88M |
Long-Term Debt | -- | -- | 139.00K | 283.00K | 950.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 338.00K | 395.00K | 437.00K | 488.00K | 537.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 10.11M | 9.93M | 10.68M | 9.61M | 11.36M |
|
|||||
Common Stock & APIC | 426.68M | 425.51M | 423.77M | 423.26M | 419.46M |
Retained Earnings | -430.53M | -426.83M | -420.86M | -417.16M | -415.33M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -3.86M | -1.32M | 2.91M | 6.10M | 4.14M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | 689.00K |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | 689.00K |
|
|||||
Total Common Equity | -3.86M | -1.32M | 2.91M | 6.10M | 4.14M |
Total Preferred Equity | -- | -- | -- | -- | 689.00K |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -3.86M | -1.32M | 2.91M | 6.10M | 4.83M |
|